Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Injectable Drug Delivery Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Injectable Drug Delivery Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Global Injectable Drug Delivery Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Global Injectable Drug Delivery Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Devices
       1.1. Conventional Injection Devices
        1.1.1. By Material
         1.1.1.1. Glass
         1.1.1.2. Plastic
        1.1.2. By Product
         1.1.2.1. Fillable Syringes
         1.1.2.2. Prefilled Syringes
        1.1.3. By Usability
         1.1.3.1. Reusable Injection Devices
         1.1.3.2. Disposable Injection Devices
       1.2. Self-Injection Devices
        1.2.1. Needle-Free Injectors
         1.2.1.1. By Product
          1.2.1.1.1. Fillable Needle-Free Injectors
          1.2.1.1.2. Prefilled Needle-Free Injectors
         1.2.1.2. By Technology
          1.2.1.2.1. Jet-Based Needle-Free Injectors
          1.2.1.2.2. Spring-Based Needle-Free Injectors
          1.2.1.2.3. Laser-Powered Needle-Free Injectors
          1.2.1.2.4. Vibration-Based Needle-Free Injectors
         1.2.1.3. By Usability
          1.2.1.3.1. Reusable Needle-Free Injectors
          1.2.2.3.2. Disposable Needle-Free Injectors
        1.2.2. Autoinjectors
         1.2.2.1. By Product
          1.2.2.1.1. Fillable Autoinjectors
          1.2.2.1.2. Prefilled Autoinjectors
         1.2.2.2. By Technology
          1.2.2.2.1. Automated Autoinjectors
          1.2.2.2.2. Manual Autoinjectors
         1.2.2.3. By Design
          1.2.2.3.1. Standardized Autoinjectors
          1.2.2.3.2. Customized Autoinjectors
         1.2.2.4. By Usability
          1.2.2.4.1. Reusable Autoinjectors
          1.2.2.4.2. Disposable Autoinjectors
        1.2.3. Pen Injectors
         1.2.3.1. By Product
          1.2.3.1.1. Single-Chambered Pen Injectors
          1.2.3.1.2. Dual-Chambered Pen Injectors
         1.2.3.2. By Design
          1.2.3.2.1. Standard Pen Injectors
          1.2.3.2.2. SCustomized Pen Injectors
         1.2.3.3. By Usability
          1.2.3.3.1. Reusable Pen Injectors
          1.2.3.3.2. Disposable Pen Injectors
        1.2.4. Wearable Injectors
        1.2.5. Other Devices
      2. Formulations
       2.1. Conventional Drug Delivery formulations
        2.1.1. Solutions
        2.1.2. Reconstituted/Lyophilized formulations
        2.1.3. Suspensions
        2.1.4. Emulsions
       2.2. Novel Drug Delivery formulations
        2.2.1. Colloidal Dispersions
         2.2.1.1. Niosomes
         2.2.1.2. Liposomes
         2.2.1.3. Polymeric/Mixed Micelles
         2.2.1.4. Nanoparticles
          2.2.1.4.1. Solid-Lipid Nanoparticles
          2.2.1.4.2. Nanoemulsions
        2.2.2. Microparticles
         2.2.2.1. Microspheres
         2.2.2.2. Microcapsules
       2.3. Long-Acting Injection formulations

• 8.   Global Injectable Drug Delivery Market, By Formulation Packaging Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Ampules
      2. Vials
      3. Cartridges
      4. Bottles

• 9.   Global Injectable Drug Delivery Market, By Therapeutic Usage Pattern Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Auto-immune diseases
       1.1. Rheumatoid Arthritis
       1.2. Multiple Sclerosis (Ms)
       1.3. Crohn’s Disease
       1.4. Psoriasis
       1.5. Other Autoimmune Diseases
      2. Hormonal Disorders
       2.1. Diabetes
       2.2. Anemia'
       2.3. Reproductive Health Disease
       2.4. Antithrombotic/Thrombolytic Therapy
       2.5. Osteoporosis
       2.6. Growth Hormone Deficiency (Ghd)
      3. Orphan Diseases
      4. Oncology
      5. Other Therapeutic Applications
       5.1. Pain Management
       5.2. Allergies
       5.3. Aesthetic Treatment
       5.4. Hepatitis C
       5.5. Hemophilia

• 10.   Global Injectable Drug Delivery Market, By Usage Pattern Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Curative Care
      2. Immunization
      3. Other Usage Pattern

• 11.   Global Injectable Drug Delivery Market, By Site of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Skin
      2. Circulatory/Musculoskeletal
      3. Organs
      4. Central Nervous System

• 12.   Global Injectable Drug Delivery Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Hospitals
      2. Retail Pharmacy Stores

• 13.   Global Injectable Drug Delivery Market, By By Facility of Use Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Hospitals and Clinics
      2. Home Care Settings
      3. Other Facilities of Use

• 14.   North America Injectable Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 15.   Latin America Injectable Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 16.   Europe Injectable Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
          2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 17.   Asia Pacific Injectable Drug Delivery Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 18.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 19.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 20.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. Baxter International, Inc.
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Becton, Dickinson and Company
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Gerresheimer Ag
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Pfizer, Inc.
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Eli Lilly and Company
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Sandoz (A Division of Novartis Ag)
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Terumo Corporation
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Teva Pharmaceutical Industries Ltd.
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. SHL Group
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Schott AG
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11.West Pharmaceutical Services, Inc.
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview
      12.Insulet Corporation
       12.1. Company Overview
       12.2. Product Portfolio
       12.3. SWOT Analysis
       12.4. Financial Overview
       12.5. Strategic Overview
      13.Elcam Medical
       13.1. Company Overview
       13.2. Product Portfolio
       13.3. SWOT Analysis
       13.4. Financial Overview
       13.5. Strategic Overview
      14.Ypsomed AG
       14.1. Company Overview
       14.2. Product Portfolio
       14.3. SWOT Analysis
       14.4. Financial Overview
       14.5. Strategic Overview

• 21.   Pre and Post COVID-19 Impact
  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations
    
• 22.   FutureWise SME Key Takeaway Points for Client